TCT 76: Six Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Sirolimus-Eluting Stents for Bifurcation Lesions – Insights From the I-LOVE-IT 2 Trial

Presenter: Bo Xu

REGISTER for free or LOG IN to view this content

TCT 76: Six Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention With Biodegradable-Polymer Sirolimus-Eluting Stents for Bifurcation Lesions – Insights From the I-LOVE-IT 2 Trial

We Recommend